Accessibility Menu
Ono Pharmaceutical logo

Ono Pharmaceutical

(OTC) OPHLY

Current Price$4.98
Market Cap$7.02B
Since IPO (2012)+27%
5 Year-23%
1 Year+44%
1 Month+9%

Ono Pharmaceutical Financials at a Glance

Market Cap

$7.02B

Revenue (TTM)

¥522.75B

Net Income (TTM)

¥70.78B

EPS (TTM)

$0.33

P/E Ratio

15.04

Dividend

$0.09

Beta (Volatility)

0.22 (Low)

Price

$4.98

Volume

29,436

Open

$4.97

Previous Close

$4.98

Daily Range

$4.96 - $5.00

52-Week Range

$3.41 - $5.75

Estimated Earnings Date

Aug 3, 2026

OPHLY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ono Pharmaceutical

Industry

Pharmaceuticals

Employees

4,206

CEO

Gyo Sagara

Headquarters

Osaka, 541-8564, JP

OPHLY Financials

Key Financial Metrics (TTM)

Gross Margin

72.52%

Operating Margin

20.03%

Net Income Margin

13.53%

Return on Equity

8.54%

Return on Capital

11.23%

Return on Assets

6.31%

Earnings Yield

6.65%

Dividend Yield

1.72%

Payout Ratio

53.80%

Stock Overview

Market Cap

$7.02B

Shares Outstanding

1.41B

Volume

29.44K

Avg. Volume

37.84K

Financials (TTM)

Gross Profit

¥379.16B

Operating Income

¥103.58B

EBITDA

¥142.47B

Operating Cash Flow

¥140.14B

Capital Expenditure

-¥6.00B

Free Cash Flow

¥134.15B

Cash & ST Invst.

¥238.13B

Total Debt

¥121.46B

Ono Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

¥120.93B

+7.7%

Gross Profit

¥87.26B

+30.1%

Gross Margin

72.16%

N/A

Market Cap

$7.02B

N/A

Market Cap/Employee

$1.82M

N/A

Employees

3,853

N/A

Net Income

¥833.03M

+112.7%

EBITDA

¥22.42B

+487.4%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

¥238.13B

+13.2%

Total Debt

¥121.46B

-17.2%

Accounts Receivable

¥146.57B

+8.6%

Inventory

¥57.70B

-22.9%

Long Term Debt

¥82.83B

-27.0%

Short Term Debt

¥38.63B

+16.4%

Return on Assets

6.31%

N/A

Return on Invested Capital

10.96%

N/A

Free Cash Flow

¥49.80B

+32.5%

Operating Cash Flow

¥50.81B

+30.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KYKOFKyowa Kirin Co., Ltd.
$14.43+0.00%
GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited
$2.34+0.00%
HKMPYHikma Pharmaceuticals PLC
$41.21-0.05%
FLMNFFielmann AG
$50.75+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About OPHLY

What is the current price of Ono Pharmaceutical?

Ono Pharmaceutical is trading at $4.98 per share.

What is the 52-week range for Ono Pharmaceutical?

Over the past 52 weeks, Ono Pharmaceutical has traded between $3.41 and $5.75.

How much debt does Ono Pharmaceutical have?

As of the most recent reporting period, Ono Pharmaceutical reported total debt of ¥760.17M.

How much cash does Ono Pharmaceutical have on hand?

Ono Pharmaceutical reported ¥1.49B in cash and cash equivalents in its most recent financial results.

What is Ono Pharmaceutical’s dividend yield?

Ono Pharmaceutical currently has a dividend yield of 1.72%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.